TLR2, TLR4, and TLR5 are essential molecules in innate immunity to defend against pathogens in the genitourinary tract, and calcineurin inhibitors, especially tacrolimus, have been reported to decrease TLR5 expression in bladder macrophages while developing UTI (21, 22). The gene discussed is TLR4; the disease is bacterial urinary tract infection.